Research Articles | Page 22 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients Feb 2013 Leukemia myelodysplastic syndromes (MDS)
Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation Mar 2014 J Natl Cancer Inst myelodysplastic syndromes (MDS)
Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS) Jan 2021 Cancer Causes & Control : CCC myelodysplastic syndromes (MDS)
Risk and timing of cardiovascular death among patients with myelodysplastic syndromes Oct 2017 Blood Advances myelodysplastic syndromes (MDS)
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial Mar 2016 Lancet Oncol myelodysplastic syndromes (MDS)
Rigosertib in Combination With Azacitidine in Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia: Results of a Phase 1 Study Jul 2020 Leukemia Research acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Rewriting the rules for care of MDS and AML patients in the time of COVID-19 Apr 2020 Leukemia Research Reports acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Revisiting use of growth factors in myelodysplastic syndromes May 2012 Asian Pac J Cancer Prev myelodysplastic syndromes (MDS)
Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes Jun 2012 Blood myelodysplastic syndromes (MDS)
Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Jun 2013 J Clin Oncol myelodysplastic syndromes (MDS)
Share with addtoany.com.